Journal article
Necroptotic movers and shakers: cell types, inflammatory drivers and diseases
Ashley Weir, Sebastian Hughes, Maryam Rashidi, Joanne M Hildebrand, James E Vince
CURRENT OPINION IN IMMUNOLOGY | CURRENT BIOLOGY LTD | Published : 2021
Abstract
The necroptotic cell death pathway has received significant attention for its ability to trigger inflammatory responses and its potential involvement in related conditions. Recent insights into the essential membrane damaging necroptotic pseudokinase effector, Mixed lineage kinase domain like (MLKL), have revealed a number of diverse MLKL functions that contribute to the inflammatory nature of necroptosis. Here we review distinct MLKL signalling roles and document the immunogenic molecules released by necroptosis. We discuss specific in vivo MLKL-driven responses, the activation of inflammasome complexes and innate lymphoid cells, which have been documented to drive disease. Finally, we list..
View full abstractGrants
Awarded by National Health and Medical Research Council of Australia
Awarded by National Health and Medical Research Council
Awarded by operational infrastructure grants through the Australian Government Independent Research Institute Infrastructure Support Scheme
Funding Acknowledgements
We apologise to authors whose work we were unable to discuss or cite due to space constraints. JEV is supported by National Health and Medical Research Council of Australia project grants (1145788 and 1101405), an ideas grant (1183070) and fellowship (1141466). M.R. is supported by a Mathison Centenary fellowship, The University of Melbourne. J.M.H is supported by a National Health and Medical Research Council fellowship (1142669). This work was also supported by operational infrastructure grants through the Australian Government Independent Research Institute Infrastructure Support Scheme (9000587) and the Victorian State Government Operational Infrastructure Support, Australia.